| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 |
| filingDate |
2002-03-29^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe9ecc3f0bb41cfdd08499721067fcee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f17ade93711e425f81ada0955bf52c86 |
| publicationDate |
2002-11-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002173537-A1 |
| titleOfInvention |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level |
| abstract |
2-pyrrolidinone derivatives which have in position 4 at least one substituent are described herein. Methods of treating polygltamine disorders such as Huntington's disease, dentorubropallidoluysian atrophy (DRPLA), spinal and bulbar muscular atrophy (SBMA), and spinocerebellar ataxias with 2-pyrrolidinone derivatives are also descibed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004152778-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019152688-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8048923-B2 |
| priorityDate |
1997-11-18^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |